EP4021420A4 - System und verfahren zur multiwirkstofffreisetzung - Google Patents
System und verfahren zur multiwirkstofffreisetzung Download PDFInfo
- Publication number
- EP4021420A4 EP4021420A4 EP20857394.9A EP20857394A EP4021420A4 EP 4021420 A4 EP4021420 A4 EP 4021420A4 EP 20857394 A EP20857394 A EP 20857394A EP 4021420 A4 EP4021420 A4 EP 4021420A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- drug delivery
- drug
- delivery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012377 drug delivery Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
- A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
- A61J3/074—Filling capsules; Related operations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962893573P | 2019-08-29 | 2019-08-29 | |
US201962893567P | 2019-08-29 | 2019-08-29 | |
US202062981180P | 2020-02-25 | 2020-02-25 | |
US202063022823P | 2020-05-11 | 2020-05-11 | |
PCT/US2020/048107 WO2021041608A1 (en) | 2019-08-29 | 2020-08-27 | System and method of multi-drug delivery |
Publications (2)
Publication Number | Publication Date |
---|---|
EP4021420A1 EP4021420A1 (de) | 2022-07-06 |
EP4021420A4 true EP4021420A4 (de) | 2023-11-22 |
Family
ID=74683538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20857394.9A Pending EP4021420A4 (de) | 2019-08-29 | 2020-08-27 | System und verfahren zur multiwirkstofffreisetzung |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP4021420A4 (de) |
JP (1) | JP2022546496A (de) |
CN (1) | CN114650810A (de) |
AU (1) | AU2020336093A1 (de) |
BR (1) | BR112022003895A2 (de) |
CA (1) | CA3152734A1 (de) |
IL (1) | IL290961A (de) |
MX (1) | MX2022002526A (de) |
WO (1) | WO2021041608A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022040896A1 (en) * | 2020-08-25 | 2022-03-03 | Abbvie Inc. | System and method of multi-drug delivery |
US11273128B1 (en) * | 2021-04-15 | 2022-03-15 | Sandoz Ag | Elagolix formulation |
KR20230031287A (ko) * | 2021-08-26 | 2023-03-07 | 컨템포러리 엠퍼렉스 테크놀로지 씨오., 리미티드 | 액체 백, 전지 셀, 전지 및 전기 장치 |
CN113876728B (zh) * | 2021-11-17 | 2022-12-13 | 南京唯创远医药科技有限公司 | 一种噁拉戈利冻干片及其制备方法 |
EP4279075B1 (de) * | 2022-05-12 | 2024-07-10 | Zaklady Farmaceutyczne Polpharma S.A. | Pharmazeutische zusammensetzung enthaltend elagolix |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014143669A1 (en) * | 2013-03-15 | 2014-09-18 | AbbVie Inc . | Compositions for use in treating heavy menstrual bleeding and uterine fibroids |
WO2019036713A1 (en) * | 2017-08-18 | 2019-02-21 | Abbvie Inc. | SOLID PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF ENDOMETRIOSIS, UTERINE FIBROIDS, POLYKYSTIC OVARY SYNDROME AND ADENOMYOSIS |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8022053B2 (en) * | 2004-11-02 | 2011-09-20 | Bayer Schering Pharma Aktiengesellschaft | Oral solid dosage forms containing a low dose of estradiol |
US20080075772A1 (en) * | 2006-04-13 | 2008-03-27 | Lawrence Solomon | Pharmaceutical compositions having novel scoring patterns and methods of using those compositions |
WO2010014502A1 (en) * | 2008-07-31 | 2010-02-04 | Aptapharma, Inc. | Functionally coated breakable tablets |
KR101861307B1 (ko) * | 2011-10-13 | 2018-07-06 | 한미약품 주식회사 | 정제를 포함하는 경질 캡슐 복합 제형 |
US9456987B2 (en) * | 2013-04-03 | 2016-10-04 | Binutra, Inc. | Capsule with internal diaphragm |
AU2017316583A1 (en) * | 2016-08-23 | 2019-03-28 | Mylan Inc. | Child resistant medication packaging |
-
2020
- 2020-08-27 EP EP20857394.9A patent/EP4021420A4/de active Pending
- 2020-08-27 AU AU2020336093A patent/AU2020336093A1/en active Pending
- 2020-08-27 CA CA3152734A patent/CA3152734A1/en active Pending
- 2020-08-27 CN CN202080074708.5A patent/CN114650810A/zh active Pending
- 2020-08-27 JP JP2022513623A patent/JP2022546496A/ja active Pending
- 2020-08-27 BR BR112022003895A patent/BR112022003895A2/pt unknown
- 2020-08-27 MX MX2022002526A patent/MX2022002526A/es unknown
- 2020-08-27 WO PCT/US2020/048107 patent/WO2021041608A1/en active Application Filing
-
2022
- 2022-02-27 IL IL290961A patent/IL290961A/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014143669A1 (en) * | 2013-03-15 | 2014-09-18 | AbbVie Inc . | Compositions for use in treating heavy menstrual bleeding and uterine fibroids |
WO2019036713A1 (en) * | 2017-08-18 | 2019-02-21 | Abbvie Inc. | SOLID PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF ENDOMETRIOSIS, UTERINE FIBROIDS, POLYKYSTIC OVARY SYNDROME AND ADENOMYOSIS |
Non-Patent Citations (1)
Title |
---|
See also references of WO2021041608A1 * |
Also Published As
Publication number | Publication date |
---|---|
IL290961A (en) | 2022-04-01 |
AU2020336093A1 (en) | 2022-03-31 |
WO2021041608A1 (en) | 2021-03-04 |
JP2022546496A (ja) | 2022-11-04 |
EP4021420A1 (de) | 2022-07-06 |
BR112022003895A2 (pt) | 2022-05-24 |
CN114650810A (zh) | 2022-06-21 |
CA3152734A1 (en) | 2021-03-04 |
MX2022002526A (es) | 2022-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4021420A4 (de) | System und verfahren zur multiwirkstofffreisetzung | |
EP3701701A4 (de) | Konsenssystem und verfahren | |
EP3949177A4 (de) | Systeme und verfahren zur konfiguration anhand von gruppenidentifikatoren | |
EP3838804A4 (de) | Freisetzungsort und freisetzungsverfahren | |
EP3820403A4 (de) | Implantateinführungssystem und -verfahren | |
EP4057948A4 (de) | System und verfahren zum einführen eines stents | |
EP3940669A4 (de) | Verfahren zur erzeugung eines lieferplans und system zur erzeugung eines lieferplans | |
EP3958759A4 (de) | Chirurgisches system und verfahren | |
EP3884644A4 (de) | Verfahren zur sicheren kommunikation und system dafür | |
EP3894097A4 (de) | System und verfahren zur modifizierung von substraten | |
EP4079933A4 (de) | Beschichtungsvorrichtung und beschichtungsverfahren | |
EP4085317A4 (de) | System und verfahren für einen langen ruhezustand | |
EP3948228A4 (de) | Spektroskopiesystem und verfahren zur durchführung von spektroskopie | |
EP3820411A4 (de) | Implantatfreisetzungssystem und verfahren zur verwendung | |
EP3958761A4 (de) | Chirurgisches system und verfahren | |
EP3908708A4 (de) | Bioretentionssystem und verfahren zu dessen konstruktion | |
EP4069452A4 (de) | Ofensystem und verfahren zur verwendung | |
EP3991526A4 (de) | Verfahren und system zur verbindung zwischen elektronik und textilien | |
EP3990150A4 (de) | System und verfahren zur verarbeitung von lng | |
EP3919236A4 (de) | Steuerungssystem und steuerungsverfahren eines steuerungssystems | |
EP4072622A4 (de) | Medikamentenabgabesystem und -verfahren | |
EP4044760A4 (de) | Verbindungswiederaufnahmeverfahren und -vorrichtung | |
EP3993856A4 (de) | Aerosolverabreichungsvorrichtungen und anwendungsverfahren dafür | |
EP3946646A4 (de) | Synchronisierungssystem und -verfahren | |
EP3948591A4 (de) | Pharmazeutische compoundieranlage und verfahren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20220325 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230331 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20231023 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/565 20060101ALI20231017BHEP Ipc: A61J 3/10 20060101ALI20231017BHEP Ipc: A61K 31/513 20060101ALI20231017BHEP Ipc: A61K 31/567 20060101ALI20231017BHEP Ipc: A61K 45/06 20060101ALI20231017BHEP Ipc: A61J 1/03 20060101ALI20231017BHEP Ipc: A61K 9/24 20060101ALI20231017BHEP Ipc: A61J 3/07 20060101ALI20231017BHEP Ipc: A61K 9/20 20060101ALI20231017BHEP Ipc: A61K 9/48 20060101AFI20231017BHEP |